Board approves Rs 56 crore preferential convertible warrant issue

Qip At PremiumFund Raising View source PDF Explain this filing

VIRINCHI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹28.00

prior close

₹28.89

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+1.2% vs market

Software Products peers, median of 33sector-0.8%+2.5% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 2.5 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

+1.1

15m

+1.2

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+0.5+1.2-0.8+2.5

Next day

-0.9+0.0-0.9-0.2-0.7

-0.3+1.0-1.3+1.4-1.7

+1.9+2.1-0.1+1.1+0.9

-2.7+1.6-4.3+0.4-3.1

-2.7+1.2-3.9-0.5-2.2

-0.4+1.9-2.3-0.3-0.2

15d

-1.4+0.4-1.8-2.5+1.1

-4.1+1.5-5.6-3.6-0.5

-17.2-4.4-12.8-8.4-8.7

-23.7-7.2-16.5-10.9-12.8

UpDownMarket · Nifty Microcap 250Sector · Software Products peers, median of 33Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved up to 2 crore convertible warrants at Rs 28 each, above the regulatory floor price, to raise up to Rs 56 crore in cash. Vivo Bio Tech Limited, a promoter-group entity, will receive 1.6 crore warrants, and IT Peer Technologies LLC 40 lakh. Each warrant converts into one Rs 10 share within 18 months; unexercised warrants lapse and the paid amount is forfeited. Shareholders will vote at the November 15, 2025 EGM.

Likely market impact

Cash injection could strengthen the company, but warrant conversion will increase share count and dilute existing holders; shareholder approval is pending.